Welcome message from the Editor-in-chief 2024

Abstract

As we come to the end of 2024, I extend my profound appreciation to our numerous Authors and Members of the Clinical and Scientific Communities for their resolute dedication, loyalty and support for the Health Sciences Investigations Journal since 2020.Amidst the challenges and difficulties, we face as a Journal, the Editorial Team, Technical Team and the Secretariat have demonstrated unwavering commitment to improving the quality of manuscripts submitted for publication. Collectively as a Team, we have made tremendous progress attracting manuscripts from several Authors across the globe.It is with much pleasure that I welcome you to volume 6 issue 2 of the Health Sciences Investigations [HSI] Journal.

The HSI Journal remains committed to reaching the global community with open-access publications from basic and clinical health sciences. Reflecting on our journey together since the inception of the Journal, I am elated of what we have
achieved as a Journal. Our dedication, commitment and discipline have enhanced our reputation as one of the leading Journals locally and internationally. In the current issue of the HSI Journal we have featured 22 manuscripts, comprising 20
original articles, a case-control study and a mini-review of 2randomized controlstudies. The substantial increase in the number of articles published in this issue indicates the level of visibility attained and acceptance of the HSI Journal by the
scientific and clinical communities. 

In this issue of the HSI Journal, we present an article on the efficacy of herbal medicines in the management of sickle cell disease [SCD]. In Ghana and across countries, plants are crucial to the health of individuals and the community because they have been used in the treatment of several diseases including jaundice, neurogenerativediseases and inflammation. The WHO recommends the integration of ethnomedicines into primary healthcare because about 70 to 95 percent of people especially in developing countries rely on them. SCD is a chronic illness with catastrophic psychological and clinical implications, prompting many affected patients to seek treatment outside of conventional medicine. In this review article, the authors highlighted the potential benefits of using phytomedicines [Niprisan® and Ciklavit®] for the management of SCD and suggested that Niprisan® and Ciklavit® may be used as adjunctive therapies to mitigate the painful episodes that characterize SCD thus improving patients' quality of life. Another interesting article is the use of D-Limonene as a solvent in the softening and removal of gutta-percha during re-endodontic treatment as compared to Eucalyptol and Chloroform in the chemomechanical removal of Root Canal Treatment (RCT). The most commonly used solvents for softening gutta-percha are Chloroform and Eucalyptol.